Dartmouth-Hitchcock Medical Center Clinical Trials
Sponsors / Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov lists 386 trials for which Dartmouth-Hitchcock Medical Center is named as lead sponsor. Of these, 36 are recruiting, 10 are active without new recruitment, and 273 have completed. The registry records 44 terminated or withdrawn trials for Dartmouth-Hitchcock Medical Center. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Planned participant enrollment across these trials sums to 2,433,892. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
386
Total Trials
36
Recruiting
10
Other Active
273
Completed
44
Terminated / Withdrawn
2,433,892
Total Enrollment
Termination reasons: Recruitment43% · Other27% · Funding11% · Efficacy9% · Regulatory5% · Safety5%
Recent Terminations
- Lumbar Puncture"An interim analysis was conducted, and no difference was found between traditional lumbar punctures and ultrasound-guided lumbar punctures. The study was subsequently terminated."
- Vaccine Hesitancy"Inability to recruit"
- Depression, Bipolar
- NCT03935178 Stopped Jan 2022Acute Coronary Syndrome"funding"
- Thoracic Neoplasm"Enrollment was closed as efforts had become more challenging, and the lab indicated that they were able to obtain their primary objective with the number that had already been enrolled."
- Chronic Graft-versus-host-disease"Insufficient accrual"
- Advance Care Planning"The effectiveness trial was terminated early because the intervention proved to be ineffective in generating engagement from study participants. With such low engagement we were unable to test our intervention with our proposed outcome meas"
- Lung Cancer"feasibility of study recruitment"
- Obesity"COVID-19"
- Contraception"High incidence of fraudulent enrollment."
Active Trials (10 total)
- NCT07226869
- NCT05626049
- Autism NANCT07420478
- NCT06001736
- NCT06391489
- Adjuvant Treatment PHASE2NCT07071038
- Cognition NANCT07109505
- NCT06258993
- NCT06548061
- Acute Myeloid Leukemia PHASE3NCT03480360
- NCT05833334
- Astrocytoma PHASE2NCT05683808
- Ovarian Cancer PHASE2NCT06815497
- NCT07368647
- Breast Cancer PHASE2NCT04568616
- Advanced Breast Cancer PHASE2NCT05933395
- Metastatic Breast Cancer PHASE2NCT05716516
- NCT06260228
- NCT05235061
- NCT05982795